DD148051A5 - Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen - Google Patents

Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen Download PDF

Info

Publication number
DD148051A5
DD148051A5 DD77217956A DD21795677A DD148051A5 DD 148051 A5 DD148051 A5 DD 148051A5 DD 77217956 A DD77217956 A DD 77217956A DD 21795677 A DD21795677 A DD 21795677A DD 148051 A5 DD148051 A5 DD 148051A5
Authority
DD
German Democratic Republic
Prior art keywords
group
hydrogen
preparation
atoms
berlin
Prior art date
Application number
DD77217956A
Other languages
German (de)
English (en)
Inventor
Herbert Koeppe
Anton Mentrup
Ernst-Otto Renth
Kurt Schromm
Wolfgang Hoefke
Gojko Muacevic
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DD148051A5 publication Critical patent/DD148051A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
DD77217956A 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen DD148051A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762644833 DE2644833A1 (de) 1976-10-05 1976-10-05 Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD148051A5 true DD148051A5 (de) 1981-05-06

Family

ID=5989679

Family Applications (5)

Application Number Title Priority Date Filing Date
DD77217956A DD148051A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen
DD77217954A DD148050A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione
DD77212491A DD143074A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl bzw.benzimidazolinone
DD77217961A DD148052A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln
DD77201314A DD134642A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane

Family Applications After (4)

Application Number Title Priority Date Filing Date
DD77217954A DD148050A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione
DD77212491A DD143074A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer n-aryl bzw.benzimidazolinone
DD77217961A DD148052A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln
DD77201314A DD134642A5 (de) 1976-10-05 1977-10-03 Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane

Country Status (33)

Country Link
US (7) US4212877A (no)
JP (1) JPS5368775A (no)
AT (15) AT361908B (no)
AU (1) AU514600B2 (no)
BE (1) BE859415A (no)
BG (1) BG33153A3 (no)
CA (4) CA1101859A (no)
CS (1) CS197304B2 (no)
DD (5) DD148051A5 (no)
DE (1) DE2644833A1 (no)
DK (1) DK439077A (no)
ES (16) ES462868A1 (no)
FI (1) FI69066C (no)
FR (1) FR2394534A1 (no)
GB (3) GB1592976A (no)
GR (1) GR64229B (no)
HK (1) HK19385A (no)
HU (1) HU177173B (no)
IE (3) IE46159B1 (no)
IL (1) IL53043A (no)
LU (1) LU78240A1 (no)
MY (1) MY8500909A (no)
NL (1) NL7710840A (no)
NO (1) NO151411C (no)
NZ (1) NZ185356A (no)
PH (4) PH15763A (no)
PL (1) PL113879B1 (no)
PT (1) PT67107B (no)
SE (1) SE442400B (no)
SG (1) SG70884G (no)
SU (1) SU665801A3 (no)
YU (1) YU40484B (no)
ZA (1) ZA775905B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
FR2455572B1 (fr) * 1979-05-04 1986-07-25 Continental Pharma Derives de phenylethylamine, leur preparation et utilisation dans le traitement des affections cardiovasculaires, et compositions les contenant
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
US4379508A (en) * 1981-10-14 1983-04-12 Nestier Corporation Nesting tray with stacking keyed interlock
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) * 1983-07-09 1985-01-17 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (no) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6860524B1 (en) 1993-05-14 2005-03-01 William W. Rowley Polyolefin connectors
US6557907B2 (en) 1993-05-14 2003-05-06 William W. Rowley Polyethylene connectors
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6848719B2 (en) 2001-09-06 2005-02-01 William W. Rowley Bendable polymer-lined water heater connector
AR042132A1 (es) * 2002-11-26 2005-06-08 Smithkline Beecham Corp Compuesto de 2- hidroxi -3-(2- aril - 1, 1 - dimetiletilamino) propoxifenilo, composicion farmaceutica que lo comprende y uso del mismo para prepararla
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
WO2006060122A2 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
PL2224973T3 (pl) * 2007-11-29 2016-11-30 Środki konserwujące do kosmetyków, środków do pielęgnacji ciała i kompozycji farmaceutycznych
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284529A (no) * 1961-10-24
GB1066613A (en) * 1965-03-03 1967-04-26 Ici Ltd Naphthalene derivatives
GB1349357A (en) * 1969-11-28 1974-04-03 Teikoku Hormone Mfg Co Ltd Propylamines
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3818017A (en) * 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) * 1973-07-18 1976-11-24 Ici Ltd Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (no) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
PL113879B1 (en) 1981-01-31
AT361913B (de) 1981-04-10
ATA57280A (de) 1980-10-15
ZA775905B (en) 1979-06-27
AT362364B (de) 1981-05-11
SE7711168L (sv) 1978-05-18
ATA679377A (de) 1980-09-15
NO773384L (no) 1978-04-06
JPS6210988B2 (no) 1987-03-10
ATA57680A (de) 1980-12-15
IE46159B1 (en) 1983-03-09
ES471796A1 (es) 1979-02-01
US4255430A (en) 1981-03-10
AT361911B (de) 1981-04-10
PT67107B (de) 1980-04-07
AT363079B (de) 1981-07-10
CA1126271A (en) 1982-06-22
ATA57380A (de) 1980-10-15
AU2933377A (en) 1979-04-12
ES471803A1 (es) 1979-02-01
ATA57880A (de) 1980-10-15
PH19028A (en) 1985-12-06
ES471806A1 (es) 1979-02-01
AT361915B (de) 1981-04-10
FI69066C (fi) 1985-12-10
FI69066B (fi) 1985-08-30
IE46158B1 (en) 1983-03-09
ES471800A1 (es) 1979-02-01
BE859415A (fr) 1978-04-05
ATA58080A (de) 1981-04-15
AT363080B (de) 1981-07-10
US4381309A (en) 1983-04-26
GB1592977A (en) 1981-07-15
YU236977A (en) 1983-01-21
ES471807A1 (es) 1979-02-01
IL53043A (en) 1982-01-31
ATA56780A (de) 1980-09-15
CA1127643A (en) 1982-07-13
NL7710840A (nl) 1978-04-07
PT67107A (de) 1977-11-01
YU40484B (en) 1986-02-28
PH15763A (en) 1983-03-22
SG70884G (en) 1985-04-04
AT362362B (de) 1981-05-11
PL201286A1 (pl) 1978-12-04
ATA57180A (de) 1980-09-15
FR2394534B1 (no) 1982-04-30
ATA57480A (de) 1980-10-15
DD134642A5 (de) 1979-03-14
ES471797A1 (es) 1979-02-01
GB1592975A (en) 1981-07-15
NO151411B (no) 1984-12-27
CS197304B2 (en) 1980-04-30
ES471794A1 (es) 1979-02-01
US4256756A (en) 1981-03-17
AU514600B2 (en) 1981-02-19
ES471799A1 (es) 1979-02-01
US4604468A (en) 1986-08-05
US4296117A (en) 1981-10-20
IE822409L (en) 1978-04-05
FI772823A (fi) 1978-04-06
IE46160B1 (en) 1983-03-09
ATA57580A (de) 1980-12-15
AT361912B (de) 1981-04-10
ES471795A1 (es) 1979-02-01
AT363081B (de) 1981-07-10
AT362365B (de) 1981-05-11
SE442400B (sv) 1985-12-23
ES471805A1 (es) 1979-02-01
GB1592976A (en) 1981-07-15
ATA57780A (de) 1980-12-15
ATA57980A (de) 1980-12-15
JPS5368775A (en) 1978-06-19
HU177173B (en) 1981-08-28
AT361914B (de) 1981-04-10
GR64229B (en) 1980-02-14
ES462868A1 (es) 1978-12-16
DK439077A (da) 1978-04-06
LU78240A1 (no) 1979-02-02
ES471801A1 (es) 1979-02-01
DD148052A5 (de) 1981-05-06
US4343800A (en) 1982-08-10
ATA56880A (de) 1980-09-15
DE2644833A1 (de) 1978-04-20
AT361908B (de) 1981-04-10
FR2394534A1 (fr) 1979-01-12
ES471808A1 (es) 1979-02-01
AT363082B (de) 1981-07-10
PH18363A (en) 1985-06-13
DD148050A5 (de) 1981-05-06
ES471804A1 (es) 1979-02-01
SU665801A3 (ru) 1979-05-30
AT362363B (de) 1981-05-11
ES471802A1 (es) 1979-02-01
NZ185356A (en) 1981-05-01
MY8500909A (en) 1985-12-31
ATA57080A (de) 1980-09-15
IE46158L (en) 1978-04-05
CA1101859A (en) 1981-05-26
BG33153A3 (en) 1982-12-15
NO151411C (no) 1985-04-10
HK19385A (en) 1985-03-22
ES471798A1 (es) 1979-02-01
US4212877A (en) 1980-07-15
DD143074A5 (de) 1980-07-30
PH16053A (en) 1983-06-09
AT364828B (de) 1981-11-25
IE822410L (en) 1978-04-05
CA1125751A (en) 1982-06-15
ATA56980A (de) 1980-09-15
IL53043A0 (en) 1977-12-30

Similar Documents

Publication Publication Date Title
DD148051A5 (de) Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen
DE2609645A1 (de) Aminoalkylheterocyclen
EP0026848A1 (de) Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
DE1593579B1 (de) Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung
DE1445186B2 (de) 3,3'-Di-2-imidazolin-2-yl-carbanilid
DE1568277A1 (de) Verfahren zur Herstellung von neuen,optisch aktiven Phenylisopylamin-Derivaten
DE2454107A1 (de) Substituierte harnstoff-, acylharnstoff- und sulfonylharnstoff-derivate und verfahren zu deren herstellung
DE2155132A1 (de) l-(2-Hydroxy-3-phenoxy- oder-phenylthic~propyl)-piperazin-Derivate
CH385196A (de) Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate
AT242150B (de) Verfahren zur Herstellung von neuen, substituierten Dihydrochinoxalonen-(2) sowie von deren Salzen und quaternären Ammoniumverbindungen
DE3403778A1 (de) Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan
DE942149C (de) Verfahren zur Herstellung substituierter Glycinamide
DE1239315B (de) Verfahren zur Herstellung von substituierten Hydrazinverbindungen
DE1018869B (de) Verfahren zur Herstellung von Aminoalkylpurinderivaten
AT314530B (de) Verfahren zur Herstellung von neuen 5- bzw. 4-Nitroimidazolderivaten und ihren Salzen
DE1215729B (de) Verfahren zur Herstellung von neuen Bis-alkanolaminderivaten und deren Salzen
DE2212526A1 (de) Verfahren zur Herstellung von optisch aktiven 1,4-Benzodiazepinen
AT356666B (de) Verfahren zur herstellung von neuen ureidophenoxyalkanolamin-derivaten und deren saeureadditionssalzen
AT213864B (de) Verfahren zur Herstellung von neuen analgetisch wirksamen α-Amino-β-oxybuttersäureamiden
DE1695580C (de) Quaternare Verbindungen des Benzil saure beta piperidino athylesters und ein Verfahren zu ihrer Herstellung
AT265275B (de) Verfahren zur Herstellung von 10-Aminoalkyl-5,5-dialkylacridanen und von deren pharmazeutisch verträglichen Salzen
AT319960B (de) Verfahren zur Herstellung von neuen Pyridazinverbindungen
AT210886B (de) Verfahren zur Herstellung von neuen, basisch substituierten Diphenylcarbinolestern und deren Salzen
CH464225A (de) Verfahren zur Herstellung von basischen Thymyläthern
DE1078581B (de) Verfahren zur Herstellung von 1, 3-Dioxolanyl-(4)-methylaethern von o-Vanillinsaeureamiden